Autres langues Telesis Bio, Inc.

Actions

TBIO

US1920031010

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,33 ^USD	-6,83%		+3,64%	-17,29%

18/04	Telesis Bio, Inc. annonce la nomination d'Eric Esser au conseil d'administration	CI
18/04	Telesis Bio Inc. annonce un recentrage stratégique sur la plateforme de synthèse enzymatique d'ADN (EDS) Gibson Sola, qui change la donne, et sur les solutions d'ARNm BioXp	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership	18/04
Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors	18/04
Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions	18/04
Telesis Bio, Inc. Announces Chief Executive Officer Changes	18/04
Telesis Bio : Shareholder Meeting - Form 8-K	08/04
Telesis Bio: Q4 Earnings Snapshot	28/03
Earnings Flash (TBIO) TELESIS BIO Reports Q4 Revenue $7M	28/03
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results	28/03
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Telesis Bio, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023	28/03
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA	27/02
Telesis Bio, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	26/02
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	26/02
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	26/02
Thinking about buying stock in Telesis Bio, Sellas Life Sciences, Mitek Systems, Monopar Therapeutics, or Inpixon?	23/02
Earnings Flash (TBIO) TELESIS BIO Posts Q3 Revenue $5.6M, vs. Street Est of $7.4M	13/11
Telesis Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Telesis Bio Reports Third Quarter 2023 Financial Results	13/11
Telesis Bio Reports Third Quarter 2023 Financial Results	13/11
Telesis Bio, Inc. Provides Earnings Guidance for 2023	13/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Telesis Bio, Inc.

Actions

TBIO

US1920031010

Autres langues

Filtres